Internal Medicine, Endocrinology, Diabetes, & Metabolism · Cape May Court House, NJ
NPI
1669630109
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
11 Village Dr
Cape May Court House, NJ, 08210
Phone (609) 465-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$181K
5,889 services
Medicare patients, 2024
640
Average age 73
Drug cost, 2024
$3.9M
8,669 prescriptions
Company payments, 2025
$5,511
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anita P Raghuwanshi was code J0897 (injection, denosumab, 1 mg), 4,140 times for 56 patients. In total Anita P Raghuwanshi billed 5,889 services in 24 codes, and Medicare paid $181K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,140 | 56 | $18.01 | $75K |
| 99214 Office E&M - Established | Office | 444 | 399 | $89.74 | $40K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 391 | 358 | $13.29 | $5,195 |
| 99215 Office E&M - Established | Office | 280 | 201 | $139.01 | $39K |
| 95251 Test - Miscellaneous | Office | 211 | 132 | $26.43 | $5,577 |
| 96372 Injection Administration | Office | 100 | 63 | $11.51 | $1,151 |
| 83036 Blood Count | Office | 97 | 91 | $9.52 | $923 |
| 82962 Clinical Chemistry | Office | 80 | 77 | $3.21 | $257 |
| 99204 Office E&M - New | Office | 33 | 33 | $127.62 | $4,211 |
| 99205 Office E&M - New | Office | 32 | 32 | $150.71 | $4,823 |
| 95249 Test - Miscellaneous | Office | 24 | 23 | $51.55 | $1,237 |
By year: 2022 $189K for 5,871 services; 2023 $151K for 3,852 services; 2024 $181K for 5,889 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 97 | 91 | $9.52 | $923 |
| 82962 Clinical Chemistry | 80 | 77 | $3.21 | $257 |
Medicare prescription drug claims, 2024
In 2024, the drug Anita P Raghuwanshi prescribed most often to Medicare patients was Levothyroxine Sodium, with 802 prescriptions and refills. In total Anita P Raghuwanshi wrote 8,669 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 802 | 2,207 | 247 | $10K |
| Pioglitazone Hcl Generic | 530 | 1,485 | 173 | $8,459 |
| Jardiance Empagliflozin | 435 | 1,022 | 129 | $565K |
| Ozempic Semaglutide | 409 | 869 | 113 | $796K |
| Metformin Hcl Generic | 335 | 959 | 108 | $3,086 |
| Synthroid Levothyroxine Sodium | 318 | 873 | 91 | $32K |
| Metformin Hcl Er Metformin Hcl | 318 | 858 | 105 | $4,306 |
| Rosuvastatin Calcium Generic | 242 | 699 | 83 | $4,189 |
| Liothyronine Sodium Generic | 232 | 608 | 70 | $8,905 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 222 | 554 | 115 | $21K |
| Mounjaro Tirzepatide | 199 | 325 | 47 | $336K |
| Repaglinide Generic | 190 | 520 | 67 | $8,043 |
| Farxiga Dapagliflozin Propanediol | 182 | 428 | 50 | $227K |
| Januvia Sitagliptin Phosphate | 162 | 362 | 46 | $184K |
| Alendronate Sodium Generic | 156 | 384 | 58 | $1,193 |
Brand drugs: 3,619 claims; generic drugs: 4,531 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anita P Raghuwanshi $5,511 ($5,511 in general payments such as food, travel and fees) from 11 companies. The largest payer was Madrigal Pharmaceuticals with $3,166.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 3 | $3,166 |
| Insulet Corporation PODD | 13 | $1,654 |
| Abbott Laboratories ABT | 37 | $338 |
| Novo Nordisk Inc NVO | 1 | $114 |
| Beta Bionics, Inc. BBNX | 1 | $75.19 |
| Amgen Inc. AMGN | 3 | $50.39 |
| Astellas Pharma US Inc 4503.T | 2 | $42.05 |
| Dexcom, Inc. DXCM | 1 | $19.71 |
| Sequel Med Tech, LLC | 1 | $19.2 |
| Abbvie Inc. ABBV | 1 | $18.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.